Breaking News Instant updates and real-time market news.

NKE

Nike

$81.96

-1.02 (-1.23%)

08:47
08/12/19
08/12
08:47
08/12/19
08:47

Nike entering subscription business with Nike Adventure Club, Reuters reports

Nike plans to launch a new subscription service for kids sneakers this week that seeks to woo parents with an offer of fewer trips to the shoe store in exchange for a regular fee and consistent brand loyalty, Reuters' Nivedita Balu reports. "Adventure Club" builds on Nike's SNKRS app, which notifies shoppers every time it launches a new shoe or has an exclusive sneaker at a nearby store, according to the report. The subscription service has three tiers -- $20, $30 or $50 a month -- is aimed at 2-year to 10-year olds. Reference Link

NKE Nike
$81.96

-1.02 (-1.23%)

07/11/19
ARGS
07/11/19
NO CHANGE
Target $200
ARGS
Buy
Lululemon price target raised to $200 from $195 at Argus
Argus analyst John Staszak raised his price target on Lululemon (LULU) to $200 and kept his Buy rating, saying the company has "substantial opportunities" to expand outside North America, especially in the China market. The analyst is also positive on Lululemon's strong brand, growing e-commerce sales, and prospects in the apparel sector. Staszak notes that his new price target models a forward earnings multiple of 36-times, which is in the middle of the 22- to 44-times multiples of peers like Nike (NKE), Under Armour (UA), and VF Corp (VFC).
07/29/19
JEFF
07/29/19
NO CHANGE
JEFF
Under Armour sneaker discounts down for each month in Q2, says Jefferies
Jefferies analyst Randal Konik says his firm's July webscrapes illustrate that Under Armour's (UAA) percentage of product on discount is down for each month in Q2 and in July, "suggesting continued momentum" into Q3. Under Armour product is selling out, discounting is down, and inventory is controlled, says the analyst. In his survey work, Nike (NKE) still remains top-of-mind in running, however Adidas (ADDYY) "appears to be exhibiting strength too." In basketball, Nike continues to be the dominant player, with notable traction in Giannis Antetokounmpo's first signature shoe, the Zoom Freak 1, Konik tells investors in a research note. The analyst surveyed 200 footwear retailers, discussing the dynamics of Nike, Adidas, and Under Armour in both basketball and running.
08/02/19
PIPR
08/02/19
NO CHANGE
PIPR
More tariffs could bring 'near-term pain' for retail margins, says Piper Jaffray
Piper Jaffray analyst Erinn Murphy revisited her views on the Global Lifestyle Brands group after President Trump announced a 10% tariff on all remaining goods coming from China starting September. In her group, Steven Madden (SHOO) and G-III Apparel (GIII) have the most direct incremental exposure to China. Her biggest concern, however, is that the tariffs come right into the back-to-school and holiday season. Goods have been priced and contracts for future orders have been inked, which presents "near-term pain" for gross margins as re-ticketing goods intra-season "can be tricky," Murphy tells investors in a research note. Retail stocks reacted aggressively on yesterday afternoon following Trump's tweet, which creates some opportunities, says Murphy. The analyst would be buyers of Under Armour (UAA), Nike (NKE) and VF Corp. (VFC). These names have diversified global footprints and lower than average exposure in China, she contends. On the flip side, if the Chinese consumer travels less, Ralph Lauren (RL), PVH Corp. (PVH), Tapestry (TPR), Capri Holdings (CPRI) and G-III could be hurt, cautions Murphy.
08/07/19
STFL
08/07/19
NO CHANGE
STFL
G-III, Yeti have higher than average risk from List 4 tariffs, says Stifel
Stifel analyst Jim Duffy said the direct, unmitigated impact of a proposed 10% tariff on "List 4" goods imported from China is contained to a single digit percentage headwind to calendar 2020 earnings for most of the 18 Sports and Lifestyle Brands companies he covers, though he identified G-III Apparel (GIII), Yeti (YETI) and potentially Dick's Sporting Goods (DKS) as having higher than group average exposure to the risk. He awaits more tariff details before adjusting estimates, but said he is constructive on higher-end and globally diversified brands, such as Lululemon (LULU), Columbia Sportswear (COLM), Nike (NKE), Under Armour (UAA) and VF Corp. (VFC).

TODAY'S FREE FLY STORIES

SRPT

Sarepta

$120.16

-4.81 (-3.85%)

08:26
08/20/19
08/20
08:26
08/20/19
08:26
Recommendations
Sarepta analyst commentary  »

FDA's CRL on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JMIA

Jumia Technologies

$15.45

2.31 (17.58%)

08:25
08/20/19
08/20
08:25
08/20/19
08:25
Upgrade
Jumia Technologies rating change  »

Morgan Stanley upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

CGIX

Cancer Genetics

$0.12

0.006 (5.26%)

08:25
08/20/19
08/20
08:25
08/20/19
08:25
Hot Stocks
Breaking Hot Stocks news story on Cancer Genetics »

Cancer Genetics says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGIX

Cancer Genetics

$0.12

0.006 (5.26%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Earnings
Cancer Genetics reports Q2 cont. ops. EPS (1c) vs. (3c) last year »

Reports Q2 revenue $1.5M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$104.15

1.42 (1.38%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Earnings
Medtronic sees Q2 EPS $1.27-$1.29, consensus $1.28 »

Sees Q2 revenue similar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 04

    Sep

  • 09

    Sep

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$6.70

0.29 (4.52%)

, ATRS

Antares Pharma

$3.12

-0.015 (-0.48%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Hot Stocks
Teva announces availability of EpiPen Jr generic equivalent »

Teva (TEVA) announced…

TEVA

Teva

$6.70

0.29 (4.52%)

ATRS

Antares Pharma

$3.12

-0.015 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

IYT

iShares Transportation Average

$181.54

1.76 (0.98%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Conference/Events
Federal Reserve Board Vice Chairman participates in a panel discussion »

Federal Reserve Board of…

XLK

Technology Select Sector SPDR

$79.48

1.21 (1.55%)

08:23
08/20/19
08/20
08:23
08/20/19
08:23
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$58.30

1.25 (2.19%)

08:23
08/20/19
08/20
08:23
08/20/19
08:23
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$117.31

1.44 (1.24%)

08:23
08/20/19
08/20
08:23
08/20/19
08:23
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ODP

Office Depot

$1.51

0.07 (4.86%)

08:23
08/20/19
08/20
08:23
08/20/19
08:23
Recommendations
Office Depot analyst commentary  »

Office Depot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$57.05

0.42 (0.74%)

08:23
08/20/19
08/20
08:23
08/20/19
08:23
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$61.74

0.39 (0.64%)

08:22
08/20/19
08/20
08:22
08/20/19
08:22
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$60.82

0.61 (1.01%)

08:22
08/20/19
08/20
08:22
08/20/19
08:22
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$91.41

0.88 (0.97%)

08:22
08/20/19
08/20
08:22
08/20/19
08:22
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$150.13

1.59 (1.07%)

08:22
08/20/19
08/20
08:22
08/20/19
08:22
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$261.32

2.51 (0.97%)

08:21
08/20/19
08/20
08:21
08/20/19
08:21
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PUFXF

Agraflora Organics

$0.00

(0.00%)

08:21
08/20/19
08/20
08:21
08/20/19
08:21
Hot Stocks
Agraflora Organics to acquire 50% of Eurasia Infused Cosmetics »

AgraFlora Organics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIK

Michaels

$5.42

0.235 (4.54%)

08:21
08/20/19
08/20
08:21
08/20/19
08:21
Recommendations
Michaels analyst commentary  »

Michaels price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 25

    Sep

08:21
08/20/19
08/20
08:21
08/20/19
08:21
Conference/Events
FDIC to hold a board meeting »

Board Meeting to be held…

SPY

SPDR S&P 500 ETF Trust

$292.31

3.52 (1.22%)

08:21
08/20/19
08/20
08:21
08/20/19
08:21
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.